Sungen Biomedical - Crunchbase Company Profile & Funding

Q: Where is Sungen Biomedical's headquarters?

Sungen Biomedical is located in Daxing, Beijing, China.

Q: Who invested in Sungen Biomedical?

Sungen Biomedical has 6 investors including Green Pine Capital Partners And Lishui Qiaoda Venture Capital.

Q: When was the last funding round for Sungen Biomedical?

Sungen Biomedical closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Sungen Biomedical raised to date?

Sungen Biomedical has raised obfuscated.

Overview

Sungen Biomedical

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Sungen Biomedical

CB Rank

46095

Sungen Biomedical is engaged in the development of first-in-class (FIC) antibody therapeutics.

Founded

obfuscation

Private

Series A

Daxing, Beijing, China

51-100

www.sungenbiomed.com/

Biopharma

Health Care

Medical

Funding Rounds

Series A

OBF

obfuscation

Details

Legal Name

Beijing Sungen Biomedical Technology Co., Ltd

Also Known As

舜景医药

Operating Status

Active

Company Type

For Profit

Phone Number

+86 01050986588

Contact Email

sungen@sungenbiomed.com.cn

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

SGC001

A monoclonal antibody drug developed for acute myocardial infarction treatment, currently in Phase Ib clinical trials with FDA fast track approval.

SGT003

An anti-tumor bispecific antibody presented for cancer treatment, developed using bispecific antibody technology.

Research & Development

Sungen Biomedical is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A
obfuscated obfuscation	Series A - Sungen Biomedical	6	obfuscated obfuscation	Green Pine Capital Partners	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Green Pine Capital Partners	Yes	Series A - Sungen Biomedical	Fei Luo
Green Pine Capital Partners	Yes	Series A - Sungen Biomedical	Fei Luo
Green Pine Capital Partners	Yes	Series A - Sungen Biomedical	Fei Luo
Green Pine Capital Partners	Yes	Series A - Sungen Biomedical	Fei Luo
Green Pine Capital Partners	Yes	Series A - Sungen Biomedical	Fei Luo